> > Vaxxas

Vaxxas

Vaxxas raises $49 million Series D

Vaxxas, a Brisbane, Australia-based vaccination biotech company, raised $49 million in a Series D fundraising round led by SPRIM Global Investments, LGT Crestone, and OneVentures.

Similar Health deals

06/19/2026

Moadna

Moadna raises $50,000 angel round

Moadna, a Syria-based clinic management and booking platform, raised...

06/19/2026

Ajax Therapeutics

Ajax Therapeutics acquired for $2.3B

Ajax Therapeutics, a New York and Cambridge, MA-based blood cancer drug...

06/19/2026

OffPlan

OffPlan raises $2.5M seed

OffPlan, an Atlanta-based membership-based primary care platform, raised...

06/19/2026

Houdini Bio

Houdini Bio raises £1.5M pre-seed

Houdini Bio, a London-based gene therapy durability platform, raised £1.5...

06/19/2026

Clair Health

Clair Health raises $11.6M Seed

Clair Health, a San Francisco-based women’s hormone-tracking wearable,...

06/19/2026

Clario

Clario raises $6M seed round

Clario, a Menlo Park, CA-based enterprise data cleanup platform, raised $6...

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Get the latest VC moves in your inbox

Jobs

Load more listings

Search for more jobs

Vaxxas